SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-20-000005
Filing Date
2020-04-30
Accepted
2020-04-30 09:22:09
Documents
150
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F summittherapeutics20fdec20.htm 20-F 3838941
2 EXHIBIT 2.7 sum-ex27_20191231x20f.htm EX-2.7 177140
3 EXHIBIT 4.3 sum-ex43_20191231x20f.htm EX-4.3 178979
4 EXHIBIT 4.24 sum-ex424_20190131x20f1.htm EX-4.24 105371
5 EXHIBIT 4.29 sum-ex429_20191231x20f.htm EX-4.29 43852
6 EXHIBIT 4.30 sum-ex430_20191231x20f.htm EX-4.30 43664
7 EXHIBIT 4.31 sum-ex431_20191231x20f.htm EX-4.31 43470
8 EXHIBIT 4.32 sum-ex432_20191231x20f.htm EX-4.32 73194
9 EXHIBIT 4.33 sum-ex433_20191231x20f.htm EX-4.33 78012
10 EXHIBIT 4.34 sum-ex434_20191231x20f.htm EX-4.34 77023
11 EXHIBIT 4.35 sum-ex435_20191231x20f.htm EX-4.35 76992
12 EXHIBIT 4.36 sumex436_20191231-20f.htm EX-4.36 110641
13 EXHIBIT 4.37 sum-ex437_20191231x20f.htm EX-4.37 74705
14 EXHIBIT 8.1 sum-ex81_20191231x20f.htm EX-8.1 10602
15 EXHIBIT 12.1 sum-ex121_20191231x20f.htm EX-12.1 9932
16 EXHIBIT 12.2 sum-ex122x20191231x20f.htm EX-12.2 9869
17 EXHIBIT 13.1 sum-ex131_20191231x20f.htm EX-13.1 9459
18 EXHIBIT 15.1 sumex151_20191231-20f.htm EX-15.1 2786
25 RATES comprecurrratesa01.jpg GRAPHIC 67057
26 GUTFLORA gutflora500mga01.jpg GRAPHIC 82327
27 CDIFFPIPELINE pipelinea01.jpg GRAPHIC 44392
28 PROFILE profileselectivitytablea01.jpg GRAPHIC 69188
29 PWC IMAGE pwcimage.jpg GRAPHIC 4750
30 ENROLLMENT ricodifyenrollmenta03.jpg GRAPHIC 67773
31 RIDINILAZOLE ridinilazole.jpg GRAPHIC 75042
  Complete submission text file 0001599298-20-000005.txt   17372618

Data Files

Seq Description Document Type Size
19 XBRL INSTANCE DOCUMENT smmt-20191231.xml EX-101.INS 3848140
20 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20191231.xsd EX-101.SCH 110822
21 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20191231_cal.xml EX-101.CAL 128677
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20191231_def.xml EX-101.DEF 416769
23 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20191231_lab.xml EX-101.LAB 1034865
24 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20191231_pre.xml EX-101.PRE 658234
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 20-F | Act: 34 | File No.: 001-36866 | Film No.: 20833505
SIC: 2834 Pharmaceutical Preparations